Posted inGlobal News AEGEAN Study Shows Benefit of Combination Based Immunotherapy for NSCLC By Alice GoodmanMay 10, 2023 Patients with Treatment-naive resectable non-small cell lung cancer (NSCLC) treated with neoadjuvant durvalumab… Posted by finxhost May 11, 2023
